Sky Labs CART BP Monitor ESC 2026
Analysis based on 9 articles · First reported Jul 20, 2026 · Last updated Sep 07, 2026
The positive clinical validation at a major cardiology congress could enhance Sky Labs' reputation and accelerate adoption of its CART monitor, potentially increasing sales and market share in the wearable blood pressure monitoring segment. This may also boost investor confidence in the company's technology and growth prospects.
Sky Labs presented clinical research on its ring-type blood pressure monitor, CART, at ESC Congress 2026 in Munich, Germany. The company hosted five dedicated sessions presenting new clinical data on atrial fibrillation (AF) and heart failure (HF) patients for the first time. Studies demonstrated high analyzable data rates and agreement with conventional ABPM, meeting ESH error margin criteria. The device uses PPG sensors and AI deep learning for 24-hour cuffless BP measurement. It is prescribed in over 2,000 Korean medical institutions with over 300,000 cumulative prescriptions and was recommended in the 2026 Korean Society of Hypertension Guidelines, a world-first for ring-type cuffless monitors. Sky Labs aims to expand into European and global markets.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard